["{\"step_by_step_thinking\": \"The question is about co-loss of BRCA2-RB1 associated with better prognosis for prostate cancer patients. However, there are no relevant documents provided that mention BRCA2, RB1, or their combination in the context of prostate cancer. Therefore, it's not possible to determine a clear answer based on the given information.\", \"answer_choice\": \"B\"}"]